In AF, MBF at baseline, at hyperaemia, and at CPT is reduced, whereas CVR under hyperaemic conditions is increased. Following electrical cardioversion, these findings are partly reversible and therefore most likely secondary to the arrhythmia.
BackgroundT2 mapping indicates to be a sensitive method for detection of tissue oedema hidden beyond the detection limits of T2-weighted Cardiovascular Magnetic Resonance (CMR). However, due to variability of baseline T2 values in volunteers, reference values need to be defined. Therefore, the aim of the study was to investigate the effects of age and sex on quantitative T2 mapping with a turbo gradient-spin-echo (GRASE) sequence at 1.5 T. For that reason, we studied sensitivity issues as well as technical and biological effects on GRASE-derived myocardial T2 maps. Furthermore, intra- and interobserver variability were calculated using data from a large volunteer group.MethodsGRASE-derived multiecho images were analysed using dedicated software. After sequence optimization, validation and sensitivity measurements were performed in muscle phantoms ex vivo and in vivo. The optimized parameters were used to analyse CMR images of 74 volunteers of mixed sex and a wide range of age with typical prevalence of hypertension and diabetes. Myocardial T2 values were analysed globally and according to the 17 segment model. Strain-encoded (SENC) imaging was additionally performed to investigate possible effects of myocardial strain on global or segmental T2 values.ResultsEx vivo studies in muscle phantoms showed, that GRASE-derived T2 values were comparable to those acquired by a standard multiecho spinecho sequence but faster by a factor of 6. Besides that, T2 values reflected tissue water content. The in vivo measurements in volunteers revealed intra- and interobserver correlations with R2=0.91 and R2=0.94 as well as a coefficients of variation of 2.4% and 2.2%, respectively. While global T2 time significantly decreased towards the heart basis, female volunteers had significant higher T2 time irrespective of myocardial region. We found no correlation of segmental T2 values with maximal systolic, diastolic strain or heart rate. Interestingly, volunteers´ age was significantly correlated to T2 time while that was not the case for other coincident cardiovascular risk factors.ConclusionGRASE-derived T2 maps are highly reproducible. However, female sex and aging with typical prevalence of hypertension and diabetes were accompanied by increased myocardial T2 values. Thus, sex and age must be considered as influence factors when using GRASE in a diagnostic manner.Electronic supplementary materialThe online version of this article (doi:10.1186/s12968-015-0118-0) contains supplementary material, which is available to authorized users.
Automated threshold-based 3D segmentation enables accurate and reproducible dual-source CT assessment of LV volume and function with excellent correlation with results of 2D short-axis analysis. Exclusion of papillary muscles from LV volume results in small systematic differences in quantitative values.
In combined PET/CT studies, x-ray attenuation information from the CT scan is generally used for PET attenuation correction. Iodine-containing contrast agents may induce artifacts in the CT-generated attenuation map and lead to an erroneous radioactivity distribution on the corrected PET images. This study evaluated 2 methods of thresholding the CT data to correct these contrast agent-related artifacts. Methods: PET emission and attenuation data (acquired with and without a contrast agent) were simulated using a cardiac torso software phantom and were obtained from patients. Seven patients with known coronary artery disease underwent 2 electrocardiography-gated CT scans of the heart, the first without a contrast agent and the second with intravenous injection of an iodine-containing contrast agent. A 20-min PET scan (single bed position) covering the same axial range as the CT scans was then obtained 1 h after intravenous injection of 18 F-FDG. For both the simulated data and the patient data, the unenhanced and contrast-enhanced attenuation datasets were used for attenuation correction of the PET data. Additionally, 2 threshold methods (one requiring user interaction) aimed at compensating for the effect of the contrast agent were applied to the contrast-enhanced attenuation data before PET attenuation correction. All PET images were compared by quantitative analysis. Results: Regional radioactivity values in the heart were overestimated when the contrast-enhanced data were used for attenuation correction. For patients, the mean decrease in the left ventricular wall was 23%. Use of either of the proposed compensation methods reduced the quantification error to less than 5%. The required time for postprocessing was minimal for the user-independent method. Conclusion: The use of contrast-enhanced CT images for attenuation correction in cardiac PET/CT significantly impairs PET quantification of tracer uptake. The proposed CT correction methods markedly reduced these artifacts; additionally, the user-independent method was time-efficient. Bot h PET and CT can provide valuable diagnostic and prognostic information noninvasively to guide the management of patients with heart disease. Molecular and functional PET can be used, for example, to assess myocardial perfusion, perfusion reserve, metabolism, and innervation. With morphologic CT, calcification of coronary arteries may be detected and quantified, and modern equipment even allows for the noninvasive visualization of the vessel lumen (coronary angiography). The main advantage of combined PET/CT devices over stand-alone PET and CT lies in the acquisition of both molecular and morphologic data with spatial and temporal coregistration in a single session, making data interpretation easier and quicker. It is self-evident that the PET/CT protocol has to be tailored to each patient to minimize radiation exposure and scanning time. Unnecessary scans have to be avoided. Unlike stand-alone PET scanners, attenuation correction of the PET data in PET/CT studies is usually n...
Recent studies have shown that idiopathic atrial fibrillation (AF) is associated with diminished myocardial perfusion and perfusion reserve, which are also impaired in various forms of cardiomyopathies. In many cases, AF develops during progression of dilated cardiomyopathy (DCM) and may aggravate heart failure. This study compared myocardial perfusion between patients with nonischemic DCM with and without AF. Methods: Twelve men (age 6 SD, 55 6 12 y) who had DCM and persistent AF were compared with a group of 18 men (mean age, 43 6 15 y, P 5 not statistically significant) who had DCM and sinus rhythm and with 22 healthy controls (mean age, 47 6 13 y, P 5 not statistically significant). Myocardial blood flow (MBF) was noninvasively quantified at rest and during adenosine infusion using PET and radioactive-labeled water (H 2 15 O PET). Results: Compared with controls, DCM patients without AF showed impaired hyperemic perfusion (2.52 6 1.29 vs. 3.57 6 0.88 mL/min/mL, P 5 0.014) and perfusion reserve (2.10 6 1.01 vs. 3.37 6 0.97, P 5 0.003). However, compared with DCM patients without AF, DCM patients with AF showed an additional impairment in resting perfusion (0.82 6 0.31 mL/min/mL, P 5 0.010) and hyperemic perfusion (1.32 6 0.93 mL/min/mL, P 5 0.022), and compared with controls, DCM patients with AF showed a further diminishment of perfusion reserve (1.68 6 0.94 vs. 3.37 6 0.97, P , 0.001) accompanied by the highest coronary vascular resistance of all groups. Conclusion: Compared with patients with sinus rhythm, patients with AF have significantly reduced myocardial perfusion reserve and increased coronary resistance in nonischemic DCM. Further studies on the underlying pathomechanisms are warranted.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.